FORM 3 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION |
Washington, D.C. 20549 | |
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES | |
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the | |
Investment Company Act of 1940 |
OMB APPROVAL
OMB Number: | 3235-0104 |
Estimated average burden hours | |
per response... | 0.5 |
1. Name and Address of Reporting Person
Aghion Daniel
2. Date of Event Requiring
Statement (Month/Day/Year)
3. Issuer Name and Ticker or Trading Symbol
Oramed Pharmaceuticals Inc. [ORMP]
(Last)(First)(Middle)
1185 Avenue of the Americas
(Street) | ||
New York | NY | 10036 |
(City) | (State) | (Zip) |
01/01/2024
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X | Director | ____ | 10% Owner |
____ | Officer (give title____ | Other (specify | |
below) | below) |
- If Amendment, Date Original Filed(Month/Day/Year)
- Individual or Joint/Group Filing (Check
Applicable Line)
-
Form filed by One Reporting Person
____ Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)
2. Amount of Securities Beneficially | 3. Ownership |
Owned | Form: Direct (D) |
(Instr. 4) | or Indirect (I) |
(Instr. 5) | |
4. Nature of Indirect Beneficial Ownership (Instr. 5)
Page 1 of 2.
Table II - Derivative Securities Beneficially Owned ( e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)
2. Date Exercisable and | 3. Title and Amount of Securities | ||
Expiration Date | Underlying Derivative Security | ||
(Month/Day/Year) | (Instr. 4) | ||
Date | Expiration | Title | Amount or Number of |
Exercisable | Date | Shares | |
4. Conversion or Exercise Price of Derivative Security
5. Ownership Form of Derivative Security: Direct
(D) or Indirect (I) (Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Explanation of Responses:
Remarks:
No securities are beneficially owned.
/s/Daniel Aghion | 01/02/2024 |
**Signature of Reporting Person | Date |
- If the form is filed by more than one reporting person, see Instruction 5(b)(v).
- Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.
Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.
Page 2 of 2.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Oramed Pharmaceuticals Inc. published this content on 02 January 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 02 January 2024 18:39:37 UTC.